UA Ruhr appointment of Kathrin Thedieck – Metabolic signals pave new avenues for cancer research and rare diseases
07/01/2025
Click here to read more on the UDE or UA Ruhr website
Click here to read more on the UDE or UA Ruhr website
Click here to read more.
Click here to read more on the Klüh website. Click here toe read more on the Tuberöse Sclerose Deutschland e.V. website.
Click here to read more on UIBK. Click here to read more on ORF.
News Release, 25.01.2021 on EurekAlert! and Medical Press
Salzburger Nachrichten and Kleine Zeitung, 26.01.2021
Tiroler Tageszeitung, 26.01.2021
Tiroler Forscher entdecken Mechanismus bei Entstehung von Krebs und Epilepsie.
G3BP proteins inhibit the metabolic driver MTOR, a signaling protein that plays a central role in tumor diseases and developmental disorders of the brain. This is reported in this week´s issue of the journal Cell. The study was led by scientists from the University of Innsbruck and the German Cancer Research Center together with the Medical University of Innsbruck and a European network.
UniJubiläum Artikel 94 – 350 Jahre Universität Innsbruck